• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Digital Diabetes Market to Reach $1.5B by 2024, Research Finds

Share:

December 16, 2020

The digital diabetes market is on track to reach $1.5 billion dollars by 2024, according to a new report by Research2Guidance.

– The confident growth of digital diabetes care will be driven by the growth of the global addressable market for digital diabetes services. Between 2019 and 2024, the number of diagnosed diabetics with access to smart devices is set to increase from 109 million to 180 million.

– Digital diabetes solutions have disrupted the diabetes care market and are changing overall chronic care, targeting not only diabetes but also its various comorbidities, such as obesity, hypertension, and depression.

– The report, The Global Digital Diabetes Care Market 2020: Going Beyond Diabetes Management focuses on the continued expansion of digital diabetes providers into other chronic conditions (vertical expansion) and new service opportunities (horizontal expansion), highlighting the market’s strategic direction in the next few years. This expansion will create new revenue opportunities, improve payer acceptance, and grow user bases beyond the diagnosed diabetes audience.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

– In the report, the Top 10 market players LifeScan Inc., Ascensia Diabetes Care, Informed Data Systems (One Drop), mySugr (Roche), H2 Inc., Livongo Health, Omada Health, Abbott, Dexcom, and Dario Health are profiled with their offerings, mobile app portfolio performance, and strategy analysis, as well as Top 10 country profiles (market opportunity size, number of solutions, downloads, number of users, Top 5 players).

Source: Hit Consultant

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Sorrento Enters Into Letter Of Intent To Acquire SmartPharm And Develop Pipeline Of Gene-Encoded Therapeutic Antibodies, Starting With Neutralizing Antibodies To Treat COVID-19 and Cancer TherapeuticsSorrento Enters Into Letter Of Intent To Acquire SmartPharm And Develop Pipeline Of Gene-Encoded Therapeutic Antibodies, Starting With Neutralizing Antibodies To Treat COVID-19 and Cancer Therapeutics
  • A Smartphone Based Diagnostic Platform For Rapid Detection Of Zika Chikungunya and Dengue VirusesA Smartphone Based Diagnostic Platform For Rapid Detection Of Zika Chikungunya and Dengue Viruses
  • Get ready for a future of rampant healthcare consolidationGet ready for a future of rampant healthcare consolidation
  • Green Growth Brands Offer for Aphria Inc. ExpiresGreen Growth Brands Offer for Aphria Inc. Expires
  • Oncimmune Announces the Acquisition of Protagen Diagnostics AG, a Leader in Personalised Immuno-ProfilingOncimmune Announces the Acquisition of Protagen Diagnostics AG, a Leader in Personalised Immuno-Profiling
  • Centene Completes Acquisition of Wellcare, Creating a Leading Healthcare Enterprise Focused on Government-Sponsored Healthcare ProgramsCentene Completes Acquisition of Wellcare, Creating a Leading Healthcare Enterprise Focused on Government-Sponsored Healthcare Programs
  • Drug Pricing Reform Includes a Focus on Patents: Here’s How Pharma Can PrepareDrug Pricing Reform Includes a Focus on Patents: Here’s How Pharma Can Prepare
  • Dariohealth Closes $21.3M to Expand Digital Therapeutics Platform Beyond Diabetes and HypertensionDariohealth Closes $21.3M to Expand Digital Therapeutics Platform Beyond Diabetes and Hypertension

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications